Results

Total Results: 2,208 records

Showing results for "drug".

421. Acute Treatments for Episodic Migraine | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/migraine-treatments/protocol
     March 01, 2020 - other characteristics (e.g. older population, pregnant/breastfeeding women, patients with history of drug … screening; (5) use of prescription drug monitoring program data; (6) availability of close follow-up … screening Use of prescription drug monitoring program data Availability of close follow-up And … Drug Healthc Patient Saf. 2018;10:37-43. doi: 10.2147/DHPS.S151073. PMID: 29760569. … Canadian Headache Society Guideline: acute drug therapy for migraine headache.

422. EHC Research Protocol (Amended): Treatments for Acute Episodic Migraine (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/migraine-treatments-research-amended-protocol.pdf
     January 09, 2020 - screening; (5) use of prescription drug monitoring program data; (6) availability of close follow-up … screening • Use of prescription drug monitoring program data • Availability of close follow-up • … And others KQ 2: Any oral, injection, infusion, topical nonopioid abortive drug, including: • … Drug Healthc Patient Saf. 2018;10:37-43. doi: 10.2147/DHPS.S151073. PMID: 29760569. 17. … Canadian Headache Society Guideline: acute drug therapy for migraine headache.

423. Maternal and Fetal Effects of Mental Health Treatments in Pregnant and Breastfeeding Women: A Systematic Review of Pharmacological Interventions (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/protocol-pharm-pregnant-women_0.pdf
     December 05, 2018 - Designing drug trials: considerations for pregnant women. … Food and Drug Administration. … Pharmacoepidemiol Drug Saf. 2013 Sep;22(9):1013-8. doi: 10.1002/pds.3495. PMID: 23893932. 30. … Allergies" OR "Drug Dependency" OR "drug effects" OR "Drug Sensitivity" OR harm* OR harms OR "Long … Therapy"[Mesh] OR "drug therapy"[Subheading] OR drug*[tiab] OR pharmacotherap*[tiab] OR pharmacologic

424. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/angina-heart-attack-treatments_research-protocol.pdf
     December 11, 2012 - metabolic conversion takes place via the hepatic cytochrome P-450 isoenzymes and is susceptible to drug … Adverse drug reactions (thrombocytopenia, allergic drug reaction) 2. … reactions (thrombocytopenia, allergic drug reaction), bleeding, and stent thrombosis None 14 … The safety outcomes will be framed to help identify adverse events, including adverse drug reactions … ™ Drug-eluting stent Abbott Vascular FDA approved DESyne™ novolimus- eluting stent Drug-eluting stent

425. Data-Points-8 Tables1 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/data-points-8_tables1.pdf
     January 01, 2009 - Total Drug Cost and Out-of-Pocket Cost, by Antihypertensive Drug Class, Among Medicare Parts A, B, and … Total Drug Cost Total Out-of- Pocket Pay- ment Total Drug Cost Total Out-of- Pocket Pay … Total Drug Cost Total Out-of- Pocket Pay- ment Total Drug Cost Total Out-of- Pocket Pay … Total Drug Cost, by Antihypertensive Drug Class, Among Medicare Parts A, B, and D Beneficiaries With … Dartmouth Atlas of Health Care Maps of Total Drug Cost by Antihypertensive Drug Class Among Medicare

426. #06 Developmental Delays ADHD, and Autism (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/developmental-delays-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - Food and Drug Administration for inducing or augmenting labor and could be prescribed off label for … Food and Drug Administration (FDA). Oxytocin. [internet]. Silver Spring (MD): U.S. … Food and Drug Administration (FDA) [accessed 2013 Nov 18]. [2 p]. … Food and Drug Administration (FDA). Syntocinon. [internet]. Silver Spring (MD): U.S. … Food and Drug Administration (FDA) [accessed 2013 Nov 18]. [2 p].

427. S16 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/s16.pdf
     October 01, 2007 - The regulatory framework for the drug approval process ensures a relatively predictable body of evidence … Neither these trials nor the drug approval process itself is designed to address all the needs of the … The evidence needed for drug approval addresses only the first of 3 questions that Archie Cochrane (the … Drug coverage—Which bisphosphonate drugs should be included on a drug fomulary? … Implications of pharmacogenomics for drug development and clinical practice.

428. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/osteoporosis-bone-fracture_research-protocol.pdf
     May 14, 2010 - Food and Drug Administration (FDA) issued a warning in January 2008 linking the use of bisphosphonates … For titles obtained from the search for AEs by drug of interest, titles will be accepted if they suggest … that the manuscript includes information on the relationship between the AE and the drug. … Drug Labeling Change to Pamidronate (Aredia) Regarding Link to Renal Failure.

429. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - similar drugs in the same class are read separately), and then topics in the same class of a device, drug … Food and Drug Administration (FDA) recently approved two PET-imaging drugs for detecting beta-amyloid … ongoing clinical trials, intranasal delivery methods include needleless nostril syringes, a nasal drug … delivery methods have been used: needleless syringes inserted into alternating nostrils, a nasal drug … Exelon®), and tacrine (Cognex®) are FDA-approved cholinesterase inhibitors, and, depending on the drug

430. Arthritis and Nontraumatic Joint Disease (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1412.pdf
     December 01, 2014 - similar drugs in the same class are read separately), and then topics in the same class of a device, drug … payers similar to other uric acid–lowering drugs for treating or preventing gout, although if the drug … Patients would likely accept a new treatment option that could help them reduce their sUA if the drug … Some experts thought that as a new drug, lesinurad could be more expensive than existing options and … adding to disparities.14,15,17,18 However, some experts suspect third-party payers will cover the drug

431. Wounds and Injuries | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/wounds-and-injuries
     November 14, 2023 - for Major Joint Replacement Systematic Review Archived April 23, 2019 Long-Term Drug … Therapy and Drug Holidays for Osteoporosis Fracture Prevention: A Systematic Review Research

432. Dietary Proteins | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/dietary-proteins?page=2
     September 19, 2012 - Performance When There Is a “Gold Standard” Systematic Review Archived June 1, 2012 Drug … Arthritis in Adults: Update of a 2007 Report Systematic Review Archived June 1, 2012 Drug

433. Effective Health Care (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND__0250_05-20-2010.pdf
     January 01, 2010 - implanted cardioverters), procedures (cardioversion, surgical, ablation) Comparator(s): Different drug

434. Diabetes Mellitus (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/diabetes_hi_impact.pdf
     March 01, 2012 - Food and Drug Administration (FDA) treatment investigational new drug program to patients in the U.S … The company also reported the drug led to reduced body weight after 24 and 48 weeks of treatment. … Food and Drug Administration (FDA) guidelines set for CLS studies. … Food and Drug Administration (FDA); 2011 Feb 16 [accessed 2011 May 23]. [2 p]. … Drug pipeline. [internet].

435. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/11_peptic_ulcer_potential_high_impact_2012-12-111.pdf
     January 01, 2012 - In 2000, teduglutide received orphan drug designation for treating SBS. … In August 2011, NPS began submitting data for a new drug application to FDA for the same indication …  Key Expert Comments: Experts commenting on this drug believe that these reductions in PN could … The drug is also expected to be widely accepted by patients. … Food and Drug Administration (FDA); 2009 Oct 2 [accessed 2011 Feb 14]. [2 p].

436. Layout 1 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cancer-anemia_executive.pdf
     May 01, 2006 - epoetin alfa (Epogen®, Procrit®) and darbepoetin alfa (Aranesp®), which is a newer and longer acting drug … A review of these various trials may help maximize benefit, optimize drug usage, and minimize adverse … however, evidence is insufficient to determine if risk is lower when treatment conforms to Food and Drug … d Rationales for comparing these alternative strategies are: (1) Drug concentrations with fixed-dose … More frequent dosing schedules are less convenient, but may be more effective to maintain the desired drug

437. Topic Coming Back CER 28 DMARDs in Children with JIA NSD _SJ Clean (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/juvenile-arthritis-dmards_overview.pdf
     March 27, 2014 - Topic Coming Back CER 28 DMARDs in Children with JIA NSD _SJ Clean …

438. Evidence Summary: Comparative Effectiveness Review No. 236 Maternal, Fetal, and Child Outcomes of Mental Health Treatments in Women: A Systematic Review of Perinatal Pharmacologic Interventions (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-236-mental-health-pregnancy-evidence-summary.pdf
     April 01, 2021 - more inclusive and included studies with comparator arms comprising women with prior exposure to the drug … Studies of multiple drug exposures presented results for each exposure but did not always present results … separately for the women with multiple drug exposures. … studies with overlapping arms, we were not able to attribute the effect of the intervention to a single drug

439. Pharmacotherapy for Adults With Alcohol-Use Disorders in Outpatient Settings: Systematic Review Update (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/product/pdf/alcohol-pharma-final-protocol.pdf
     January 01, 2023 - Medications most commonly used off label in the United States for adults with AUDs Drug Class Drug … National Survey on Drug Use and Health, Detailed Tables 2019. … Drug Alcohol Depend. 2006 Feb 1;81(2):149-55. doi: 10.1016/j.drugalcdep.2005.06.007. … Drug and alcohol abuse: a clinical guide to diagnosis and treatment. 6th ed. … Neurobiological basis of drug reinforcement.

440. Treatments for Seasonal Allergic Rhinitis | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/allergy-seasonal/research-protocol
     December 01, 2020 - Food and Drug Administration (FDA) for the treatment of SAR. … Drug class review: nasal corticosteroids: final report update 1. … Drug class review: newer antihistamines: final report update 2. … Food and Drug AdministrationCenter for Drug Evaluation and Research. … Food and Drug Administration; April 2000.